Lanthanide-Enhancers in the Radiotherapy of Cancer

In Germany alone every year about 400.000 people develop cancer. The radiation ther-apy is widely used as a method of treat-ment. Cancer cells will be harmed more, because they are more sensitive than healthy cells to ionizing radiation. Neverthe-less to reduce the cancer cell growth, sig-nificantly high doses of radiation have to be used. But this leads to unwanted side-effects. Locally acting enhancers can in-crease the radiation, so that the cumulative dose is reduced and at the same time the ionizing effect in the tumor tissue itself is increased. Furthermore the radiation en-hancer should not be toxic for the healthy tissue.

Further Information: PDF

IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50

Contact
Dr. Klaus Kobek

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

Alle Nachrichten aus der Kategorie: Technology Offerings

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

An artificial cell on a chip

Researchers at the University of Basel have developed a precisely controllable system for mimicking biochemical reaction cascades in cells. Using microfluidic technology, they produce miniature polymeric reaction containers equipped with…

Specific and rapid expansion of blood vessels

Nature Communications: KIT researchers identify a new mechanism to control endothelial cell size and arterial caliber – basis for better treatment of heart infarct and stroke. Upon a heart infarct…

Climate change drives plants to extinction in the Black Forest in Germany

Climate change is leaving its mark on the bog complexes of the German Black Forest. Due to rising temperatures and longer dry periods, two plant species have already gone extinct…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close